A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem

Por Wong, William WL, Burkowski, Forbes J
Publicado em 2009

Screening for HCV

Por Wong, William W.L., Krahn, Murray
Publicado em 2014

Canadian hepatitis C virus screening guideline: a disconnect between evidence and recommendations

Por Haines, Alex, Wong, William W.L., Krahn, Murray
Publicado no CMAJ (2017)

Disease burden of chronic hepatitis B among immigrants in Canada

Por Wong, William WL, Woo, Gloria, Heathcote, E Jenny, Krahn, Murray
Publicado em 2013

Model-based projection of health and economic effects of screening for hepatitis C in Canada

Por Wong, William W.L., Erman, Aysegul, Feld, Jordan J., Krahn, Murray
Publicado no CMAJ Open (2017)

Cost‐Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma

Por Zargar, Mahdi, McFarlane, Thomas, Chan, Kelvin K.W., Wong, William W.L.
Publicado no Oncologist (2017)

Cost-effectiveness of screening for hepatitis C in Canada

Por Wong, William W.L., Tu, Hong-Anh, Feld, Jordan J., Wong, Tom, Krahn, Murray
Publicado no CMAJ (2015)

Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis

Por de Oliveira, Claire, Nguyen, Hai V., Wijeysundera, Harindra C., Wong, William W.L., Woo, Gloria, Grootendorst, Paul, Liu, Peter P., Krahn, Murray D.
Publicado em 2013